To confirm whether estrogen is indeed not able to upregulate PRSS23 expression in ERα-negative cancer cells, we treated MDA-MB-231 (ERα-negative) cells with 1 nM E2 and measured the mRNA levels of PRSS23 and pS2, with the latter serving as a positive control for estrogen responsiveness [23]. Here, PRSS23 is linked to cancer.